Brian
Analyst
Lear & Partners
Equibles does not estimate personal net worth.
About Brian
Brian is recorded as Analyst at Lear & Partners. Brian has spoken on 1 earnings call across 1 company, most recently for SAB Biotherapeutics, Inc. on November 5, 2026. The companies whose calls Brian spoke on are classified in the Healthcare sector.
Brian on recent calls
“So first, you know, given adult and adolescent cohorts here are fully enrolled in Safeguard, can you comment on if there's anything notable on the baseline characteristics of the patients in these cohorts relative to the expectations?”
Affiliation history
-
Lear & Partners
Analyst
Transcript header (unverified)
Current